Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses.

Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Abstract Text:

T Colbourn,C Asseburg,L Bojke,Z Philips,K Claxton,A E Ades,R E Gilbert,T Colbourn,C Asseburg,L Bojke,Z Philips,K Claxton,A E Ades,R E Gilbert,T Colbourn,C Asseburg,L Bojke,Z Philips,K Claxton,A E Ades,R E Gilbert,

OBJECTIVES: To determine the cost-effectiveness of prenatal strategies for preventing group B streptococci (GBS) and other serious bacterial infections in early infancy and to establish the expected value of further information. DATA SOURCES: Electronic databases were searched up to March 2006. Expert opinion was also sought. REVIEW METHODS: Twelve mutually exclusive maternal risk groups were defined at presentation in labour and the consequences considered of early-onset GBS and non-GBS bacterial infections and late onset GBS infection, measured in terms of lifetime NHS costs and quality-adjusted life-years (QALYs). These were for preterm delivery (<37 weeks): (1) planned Caesarean section, (2) previous baby with GBS disease, (3) positive urine or vaginal swab for GBS in current pregnancy, (4) fever >/=38 degrees C during labour, (5) membrane rupture >/=2 hours before labour onset, (6) membrane rupture <2 hours before labour onset. For term delivery (>/=37 weeks): (7) planned Caesarean section, (8) previous baby with GBS disease, (9) positive urine or vaginal swab for GBS in current pregnancy, (10) fever >/=38 degrees C during labour, (11) membrane rupture >/=18 hours, and (12) none of the above risk factors. Fourteen intervention strategies were applied to each maternal risk group. Data inputs were obtained from systematic reviews, primary data and expert opinion. The model parameters were simultaneously estimated from the data inputs using Bayesian evidence synthesis. The expected net benefit was calculated relative to no intervention for each intervention within each risk group for two scenarios, with and without vaccination. Interventions with more than a 1% probability of being cost-effective (i.e. maximising net benefit at a threshold of 25,000 pounds per QALY gained) in a specific risk group were combined to form strategies. To limit antibiotic exposure, women who were low risk at presentation could not be treated without a positive culture or polymerase chain reaction result. RESULTS: Current best practice, comprising intravenous treatment for pyrexia, previous GBS baby and previous GBS swab or urine culture, and oral treatment for preterm pre-labour membrane rupture (groups 2-5 and 8-10) was not cost-effective. All cost-effective options involved treatment of all preterm groups and high-risk term groups (groups 8-10). Testing high-risk women for maternal GBS colonisation would not be cost-effective, as even those with negative results would be better off treated to reduce the risk of early-onset non-GBS infection. In the absence of vaccination, culture-based testing of women in groups 11 and 12, combined with treatment for the rest, would be the most cost-effective strategy. If vaccination was available, vaccination for all and treatment for groups 1-10 would be marginally more cost-effective than treatment for groups 1-10 and culture for groups 11 and 12, but this is uncertain and is based on expert opinion on vaccine efficacy. The expected value of perfect information results suggest that moderate investment in research would be worthwhile. CONCLUSIONS: Based on our findings, immediate extension of current practice to treat all preterm and high-risk term groups would be beneficial. Further research aimed at the realisation of a GBS vaccine should be prioritised.

Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Publishing Authors By Initials

T Colbourn,C Asseburg,L Bojke,Z Philips,K Claxton,AE Ades,RE Gilbert,T Colbourn,C Asseburg,L Bojke,Z Philips,K Claxton,AE Ades,RE Gilbert,T Colbourn,C Asseburg,L Bojke,Z Philips,K Claxton,AE Ades,RE Gilbert,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Health technology assessment (Winchester, England)

VOLUME: 11

Page Numbers: 1-226

Journal Abbreviation:

ISSN: 1366-5278

DAY: 26

MONTH: Aug

YEAR: 2007

Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9706284

Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses.

AFFILIATION: Centre for Paediatric Epidemiology and Biostatistics, UCL Institute of Child Health, London, UK.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Health Technol Assess

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses Related Publications

• A male gift to its partner? Cyanogenic glycosides in the spermatophore of longwing butterflies (Heliconius).
• Absorption of Escherichia coli endotoxin (lipopolysaccharide) from the uteri of postpartum dairy cows.
• Architecture of columnar nacre, and implications for its formation mechanism.
• Blindness in Sudan: is it time to scrutinise survey methods?
• Calving sex ratio as related to the predicted Y-chromosome-bearing spermatozoa ratio in bull ejaculates.
• Carcinoma gall bladder : an institutional experience.
• Changing challenges in the control of blindness in children.
• Clinical and positron emission tomography findings of chorea associated with primary antiphospholipid antibody syndrome.
• Conjunctivitis.
• Contribution of calcium influx in mediating glucose-stimulated oxygen consumption in pancreatic islets.
• Cost, causes and rates of rehospitalization of preterm infants.
• Cyclosporin a aerosol improves the anticancer effect of Paclitaxel aerosol in mice.
• Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase.
• Highlights from the 7th general assembly, international agency for the prevention of blindness, dubai 2004.
• In vitro corrosion testing of modular hip tapers.
• Influence of bioturbation by the polychaete Nereis diversicolor on the structure of bacterial communities in oil contaminated coastal sediments.
• Mechanism and significance of early, rapid shortening in sensitized airway smooth muscle.
• Multivariate framework of the Brief Questionnaire of Smoking Urges.
• Postpartum anestrus in French beef cattle: An epidemiological study.
• Predictors of change in satisfaction with chewing ability: a 24-month study of dentate adults.
• Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses.
• Replication origin plasticity, Taylor-made: inhibition vs recruitment of origins under conditions of replication stress.
• The Halloween genes code for cytochrome P450 enzymes mediating synthesis of the insect moulting hormone.
• The diagnosis of short penis as a cause of impotentia coeundi in bulls.
• The effect of endometrial biopsy on ovulatory interval in mares.
• The many faces of the origin recognition complex.
• To step or not to step? How biochemistry and mechanics influence processivity in Kinesin and Eg5.
• Treatment of children and adolescents with tics and Tourette syndrome.
• Utility of genotyping of Mycobacterium tuberculosis in the contact investigation: a decision analysis.
• Vik1 modulates microtubule-Kar3 interactions through a motor domain that lacks an active site.